Glioblastoma Multiforme Treatment Market Is Estimated to Grow at CAGR Of 8.1%, 2022-2029 | Latest Industry Coverage by Douglas Insights
11. Januar 2023 03:52 ET
|
Douglas Insights
Isle of Man, Jan. 11, 2023 (GLOBE NEWSWIRE) -- Douglas Insights has added the Global Glioblastoma Multiforme treatment market research to its growing market reports. Douglas Insightsinsights tries...
CNS Pharmaceuticals and Image Analysis Group Partner to Further the Development of Berubicin
24. September 2020 08:00 ET
|
CNS Pharmaceuticals, Inc.
HOUSTON, Sept. 24, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) ("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel...